Cell Culture – News and Features

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells. This article explores the use of microfluidic methods for high-throughput screening of cell-based drug products.

Three-dimensional models allow researchers to better represent complex tissues and cell-cell interactions. This article explores the cell models currently used by researchers to understand disease and aid drug discovery.

Researchers discuss how organoids and organ-on-a-chip technologies are transforming women’s health research. By mimicking female-specific tissues, these models uncover new insights into diseases that affect women, such as breast cancer.

A recent study found that placenta-derived IL1α under hypoxic conditions, can greatly increase growth of human stem cell-derived liver organoids. This method offers a promising route to improve organoid models and regenerative medicine.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

Contamination is one of the main roadblocks to successful cell culture. This article explores the different types of contamination, how to identify microbial contaminants in cell culture and best practices for removal and prevention.

Researchers have developed a 3D-printable material that mimics the three-layer structure and mechanics of human skin. When printed with living cells, these skins could replace animals in the testing of cosmetics.

A new organoid model reveals details of the developing nervous system’s response to viral infections, such as Rubella. It also offers a new avenue for pharmaceutical testing.

An international research group led by the Helmholtz Centre for Infection Research has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus.

Scientists have identified a promising new drug target for acute myeloid leukemia, a deadly blood cancer with a five-year survival rate of just 30%, highlighting the crucial role of a protein called paraspeckle component 1.